Top 5 Vendors in the Global Interventional Oncology Market From 2017-2021: Technavio

Technavio has published a new report on the global interventional oncology market from 2017-2021. (Graphic: Business Wire)

LONDON--()--Technavio has announced the top five leading vendors in their recent global interventional oncology market report until 2021. This research report also lists 29 other prominent vendors that are expected to impact the market during the forecast period.

The research study by Technavio on the global interventional oncology market for 2017-2021 provides a detailed industry analysis based on procedure (oncology ablation and oncology embolization) and geography (the Americas, EMEA, and APAC).

The global interventional oncology market size is projected to grow to over USD 2,450 million by 2021, at a CAGR of more than 11% over the forecast period. The growing demand for minimally invasive procedures has led to the increasing adoption of interventional oncology, thereby positively impacting the growth of the market,” says Barath Palada, a lead analyst at Technavio for orthopedics and medical devices research.

Competitive vendor landscape

The global interventional oncology market is led by Tier 1 players, who compete with medium (Tier 2), and small (Tier 3) companies to retain their market foothold. The advances in technology and new product launches through the forecast period is expected to raise the competition among the existing vendors. Global players are increasingly adopting advanced technologies to enhance their product portfolio and retain customer loyalty. Additionally, vendors are focusing on evidence-based studies to showcase the performance, efficacy, and long-term cost-effectiveness of their products to convince medical professionals to increase their adoption of these procedures.

Request a sample report:

Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.

Top five vendors in the global interventional oncology market

Boston Scientific

Boston Scientific develops, manufactures, and markets high-quality medical devices used in the treatment of a wide range of medical conditions. Through its subsidiaries and divisions across the globe, the company improves patients' lives by providing a broad portfolio of innovative products.


BTG is a growing international healthcare business solution provider. It provides interventional medicine for cancer to improve the lives of patients and their healthcare experience. BTG offers DC Bead, LC Bead, and TheraSphere glass microspheres for embolization procedures.


Medtronic manufactures and sells device-based medical therapies worldwide. It also manufactures web-based therapy management software solutions. The company is expanding its operations in emerging countries to help patients access solutions and technologies to improve their standard of care.

Merit Medical

Merit Medical designs, develops, manufactures, and markets innovative medical products that offer a high level of quality, value, and safety to our customers. The products include diagnostic and interventional cardiology, interventional radiology, electrophysiology, thoracic surgery, interventional nephrology, oncology, pain management, outpatient access centers, CT, ultrasound, and interventional gastroenterology.


TERUMO CORPORATION develops, manufactures, imports, and markets medical devices, supplies, and accessories. The company engages in the development of a range of drug delivery devices, including TACE, micro balloon catheter, microcatheter and micro guidewires, and DEB for interventional oncology procedures.

Browse Related Reports:

Become a Technavio Insights member and access all three of these reports for a fraction of their original cost. As a Technavio Insights member, you will have immediate access to new reports as they’re published in addition to all 6,000+ existing reports covering segments like patient monitoring devices, urology devices, and vaccines. This subscription nets you thousands in savings, while staying connected to Technavio’s constant transforming research library, helping you make informed business decisions more efficiently.

About Technavio

Technavio is leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.

Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, resellers, and end-users.

If you are interested in more information, please contact our media team at


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770

Release Summary

Technavio has announced the top five leading vendors in their recent global interventional oncology market report until 2021.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 630 333 9501
UK: +44 208 123 1770